(1R,2R,4R,5R,8S,11R,13S,14S,15R,16S,19S,22S,23R,25S)-2,19-dihydroxy-13,16,23-trimethyl-6,10,17,26,27,30-hexaoxanonacyclo[23.2.2.15,14.15,15.01,23.04,22.08,13.011,16.015,19]hentriacont-28-ene-9,18,24,31-tetrone

Details

Top
Internal ID 4b02710a-852d-4f73-bd0e-f5ad5f2de556
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Physalins and derivatives
IUPAC Name (1R,2R,4R,5R,8S,11R,13S,14S,15R,16S,19S,22S,23R,25S)-2,19-dihydroxy-13,16,23-trimethyl-6,10,17,26,27,30-hexaoxanonacyclo[23.2.2.15,14.15,15.01,23.04,22.08,13.011,16.015,19]hentriacont-28-ene-9,18,24,31-tetrone
SMILES (Canonical) CC12CC3C4(C56C1C(=O)C(O5)(C7CC(C89C=CC(C(=O)C8(C7CCC6(C(=O)O4)O)C)OO9)O)OCC2C(=O)O3)C
SMILES (Isomeric) C[C@]12C[C@@H]3[C@]4([C@]56[C@H]1C(=O)[C@](O5)([C@@H]7C[C@H]([C@@]89C=C[C@@H](C(=O)[C@@]8([C@H]7CC[C@]6(C(=O)O4)O)C)OO9)O)OC[C@H]2C(=O)O3)C
InChI InChI=1S/C28H30O12/c1-22-9-16-24(3)28-17(22)19(31)27(39-28,35-10-13(22)20(32)36-16)12-8-15(29)26-7-5-14(38-40-26)18(30)23(26,2)11(12)4-6-25(28,34)21(33)37-24/h5,7,11-17,29,34H,4,6,8-10H2,1-3H3/t11-,12+,13-,14-,15+,16+,17-,22+,23-,24-,25+,26-,27+,28-/m0/s1
InChI Key IRYOOASWRCIZCK-GDRGPWMWSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C28H30O12
Molecular Weight 558.50 g/mol
Exact Mass 558.17372639 g/mol
Topological Polar Surface Area (TPSA) 164.00 Ų
XlogP -0.60
Atomic LogP (AlogP) -0.33
H-Bond Acceptor 12
H-Bond Donor 2
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1R,2R,4R,5R,8S,11R,13S,14S,15R,16S,19S,22S,23R,25S)-2,19-dihydroxy-13,16,23-trimethyl-6,10,17,26,27,30-hexaoxanonacyclo[23.2.2.15,14.15,15.01,23.04,22.08,13.011,16.015,19]hentriacont-28-ene-9,18,24,31-tetrone

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9672 96.72%
Caco-2 - 0.7705 77.05%
Blood Brain Barrier + 0.5500 55.00%
Human oral bioavailability - 0.6429 64.29%
Subcellular localzation Mitochondria 0.7520 75.20%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8169 81.69%
OATP1B3 inhibitior + 0.9267 92.67%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.6967 69.67%
BSEP inhibitior + 0.6816 68.16%
P-glycoprotein inhibitior + 0.6449 64.49%
P-glycoprotein substrate + 0.6594 65.94%
CYP3A4 substrate + 0.7392 73.92%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8679 86.79%
CYP3A4 inhibition - 0.8067 80.67%
CYP2C9 inhibition - 0.9132 91.32%
CYP2C19 inhibition - 0.9331 93.31%
CYP2D6 inhibition - 0.9599 95.99%
CYP1A2 inhibition - 0.8043 80.43%
CYP2C8 inhibition + 0.5719 57.19%
CYP inhibitory promiscuity - 0.9862 98.62%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9600 96.00%
Carcinogenicity (trinary) Non-required 0.5174 51.74%
Eye corrosion - 0.9882 98.82%
Eye irritation - 0.9121 91.21%
Skin irritation - 0.5714 57.14%
Skin corrosion - 0.9029 90.29%
Ames mutagenesis - 0.6240 62.40%
Human Ether-a-go-go-Related Gene inhibition - 0.6380 63.80%
Micronuclear - 0.8600 86.00%
Hepatotoxicity + 0.5533 55.33%
skin sensitisation - 0.8909 89.09%
Respiratory toxicity + 0.8667 86.67%
Reproductive toxicity + 0.7444 74.44%
Mitochondrial toxicity + 0.7625 76.25%
Nephrotoxicity + 0.4888 48.88%
Acute Oral Toxicity (c) I 0.3711 37.11%
Estrogen receptor binding + 0.8232 82.32%
Androgen receptor binding + 0.7846 78.46%
Thyroid receptor binding + 0.6013 60.13%
Glucocorticoid receptor binding + 0.7704 77.04%
Aromatase binding + 0.7483 74.83%
PPAR gamma + 0.6101 61.01%
Honey bee toxicity - 0.6905 69.05%
Biodegradation - 0.8250 82.50%
Crustacea aquatic toxicity + 0.5400 54.00%
Fish aquatic toxicity + 0.9738 97.38%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 97.91% 97.25%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 97.37% 85.14%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.88% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.58% 91.11%
CHEMBL3137262 O60341 LSD1/CoREST complex 93.97% 97.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 92.44% 94.45%
CHEMBL1871 P10275 Androgen Receptor 92.03% 96.43%
CHEMBL1806 P11388 DNA topoisomerase II alpha 91.33% 89.00%
CHEMBL1994 P08235 Mineralocorticoid receptor 90.88% 100.00%
CHEMBL1951 P21397 Monoamine oxidase A 89.90% 91.49%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.86% 95.56%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 86.81% 96.77%
CHEMBL5608 Q16288 NT-3 growth factor receptor 86.57% 95.89%
CHEMBL4481 P35228 Nitric oxide synthase, inducible 86.53% 94.80%
CHEMBL218 P21554 Cannabinoid CB1 receptor 86.31% 96.61%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 85.79% 97.14%
CHEMBL299 P17252 Protein kinase C alpha 84.84% 98.03%
CHEMBL259 P32245 Melanocortin receptor 4 81.68% 95.38%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 81.00% 82.69%

Cross-Links

Top
PubChem 21633629
NPASS NPC227952
LOTUS LTS0018029
wikiData Q105119306